Severe pulmonary hypertension in histiocytosis X: long-term improvement with bosentan

Eur Respir J. 2010 Jul;36(1):202-4. doi: 10.1183/09031936.00004810.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antihypertensive Agents / therapeutic use*
  • Bosentan
  • Dyspnea / drug therapy
  • Hemodynamics / drug effects
  • Histiocytosis, Langerhans-Cell / drug therapy*
  • Humans
  • Hypertension, Pulmonary / drug therapy*
  • Hypertension, Pulmonary / physiopathology
  • Male
  • Middle Aged
  • Piperazines / therapeutic use
  • Purines / therapeutic use
  • Severity of Illness Index
  • Sildenafil Citrate
  • Sulfonamides / therapeutic use*
  • Sulfones / therapeutic use

Substances

  • Antihypertensive Agents
  • Piperazines
  • Purines
  • Sulfonamides
  • Sulfones
  • Sildenafil Citrate
  • Bosentan